Study of infectious virus production from HPV18/16 capsid chimeras

Virology

Volumn 405, Issue 2, 2010, Pages 289-299

  Chen, Horng Shen ^a   Bromberg White, Jennifer ^a   Conway, Michael J ^a   Alam, Samina ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Capsid genes; Chimera; Organotypic culture; Papillomavirus; Raft culture; Virion morphogenesis

Indexed keywords

CAPSID PROTEIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LINE; CHIMERA; CONTROLLED STUDY; GENE DELETION; GENE REPLICATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROGENY; PROTEIN DOMAIN; VIROGENESIS; VIRUS CAPSID; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS VIRULENCE; WILD TYPE;

AMINO ACID SEQUENCE; CAPSID; CAPSID PROTEINS; CELLS, CULTURED; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, VIRAL; ORGAN CULTURE TECHNIQUES; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; VIRION; VIRUS ASSEMBLY;

MIRIDAE; PAPILLOMAVIRIDAE;

EID: 77955655389     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.05.019     Document Type: Article

References (78)

1. Alam S., Conway M.J., Chen H.S., Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J. Virol. 2008, 82(2):1053-1058.
2. Becker K.A., Florin L., Sapp C., Sapp M. Dissection of human papillomavirus type 33L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology 2003, 314(1):161-167.
3. Bedell M.A., Hudson J.B., Golub T.R., Turyk M.E., Hosken M., Wilbanks G.D., Laimins L.A. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 1991, 65(5):2254-2260.
4. Bishop B., Dasgupta J., Klein M., Garcea R., Christensen N., Zhao R., Chen X. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J. Biol. Chem. 2007, 282(43):31803-31811.
5. Bodily J.M., Alam S., Meyers C. Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C. Virology 2006.
6. Bodily J.M., Meyers C. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J. Virol. 2005, 79(6):3309-3321.
7. Bossis I., Roden R.B., Gambhira R., Yang R., Tagaya M., Howley P.M., Meneses P.I. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J. Virol. 2005, 79(11):6723-6731.
8. Browne H.M., Churcher M.J., Stanley M.A., Smith G.L., Minson A.C. Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. J. Gen. Virol. 1988, 69(Pt 6):1263-1273.
9. Campos S.K., Ozbun M.A. Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS ONE 2009, 4(2):e4463.
10. Carter J.J., Yaegashi N., Jenison S.A., Galloway D.A. Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae. Virology 1991, 182(2):513-521.
11. Cason J., Kambo P.K., Manse C., Jewers R.J., Best J.M. Expression of human papillomavirus type 16 (HPV-16) major (L1) and minor (L2) capsid proteins in insect cells as polyhistidine fusion proteins. Biochem. Soc. Trans. 1994, 22(3):336S.
12. Charnay N., Ivanyi-Nagy R., Soto-Rifo R., Ohlmann T., Lopez-Lastra M., Darlix J.L. Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein. Retrovirology 2009, 6:74.
13. Chen X.S., Garcea R.L., Goldberg I., Casini G., Harrison S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 2000, 5(3):557-567.
14. Conway M.J., Alam S., Christensen N.D., Meyers C. Overlapping and independent structural roles for human papillomavirus type 16L2 conserved cysteines. Virology 2009, 393(2):295-303.
15. Conway M.J., Alam S., Ryndock E.J., Cruz L., Christensen N.D., Roden R.B., Meyers C. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J. Virol. 2009, 83(20):10515-10526.
16. Da Silva D.M., Velders M.P., Nieland J.D., Schiller J.T., Nickoloff B.J., Kast W.M. Physical interaction of human papillomavirus virus-like particles with immune cells. Int. Immunol. 2001, 13(5):633-641.
17. Day P.M., Schiller J.T. Early events in the papillomaviral life cycle. Papillomavirus Research: From Natural History to Vaccines and Beyond 2006, Caister Academic Press, Norfolk. M.S. Campo (Ed.).
18. Doorbar J., Parton A., Hartley K., Banks L., Crook T., Stanley M., Crawford L. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 1990, 178(1):254-262.
19. Embers M.E., Budgeon L.R., Culp T.D., Reed C.A., Pickel M.D., Christensen N.D. Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins. Vaccine 2004, 22(5-6):670-680.
20. Fay A., Yutzy W.H.t., Roden R.B., Moroianu J. The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. J. Virol. 2004, 78(24):13447-13454.
21. Finnen R.L., Erickson K.D., Chen X.S., Garcea R.L. Interactions between papillomavirus L1 and L2 capsid proteins. J. Virol. 2003, 77(8):4818-4826.
22. Florin L., Becker K.A., Lambert C., Nowak T., Sapp C., Strand D., Streeck R.E., Sapp M. Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J. Virol. 2006, 80(13):6691-6696.
23. Florin L., Becker K.A., Sapp C., Lambert C., Sirma H., Muller M., Streeck R.E., Sapp M. Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. J. Virol. 2004, 78(11):5546-5553.
24. Florin L., Schafer F., Sotlar K., Streeck R.E., Sapp M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 2002, 295(1):97-107.
25. Frattini M.G., Lim H.B., Laimins L.A. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc Natl Acad Sci U S A 1996, 93(7):3062-3067.
26. Gambhira R., Jagu S., Karanam B., Day P.M., Roden R. Role of L2 cysteines in papillomavirus infection and neutralization. Virol. J. 2009, 6:176.
27. Giroglou T., Florin L., Schafer F., Streeck R.E., Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 2001, 75(3):1565-1570.
28. Gornemann J., Hofmann T.G., Will H., Muller M. Interaction of human papillomavirus type 16L2 with cellular proteins: identification of novel nuclear body-associated proteins. Virology 2002, 303(1):69-78.
29. Graham S.V. Late events in the life cycle of human papillomaviruses. Papillomavirus Research: From Natural History to Vaccines and Beyond 2006, Caister Academic Press, Norfolk. M.S. Campo (Ed.).
30. Grassmann K., Rapp B., Maschek H., Petry K.U., Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 1996, 70(4):2339-2349.
31. Heino P., Dillner J., Schwartz S. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles. Virology 1995, 214(2):349-359.
32. Heino P., Zhou J., Lambert P.F. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology 2000, 276(2):304-314.
33. Holmgren S.C., Patterson N.A., Ozbun M.A., Lambert P.F. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 2005, 79(7):3938-3948.
34. Jackson R.J. Translational Control of Gene Expression 2000, 127-184. Cold Spring Harbour Press, Cold Spring Harbour. N. Sonenberg, J.W.B. Hershey, M.B. Matthews (Eds.).
35. Kamper N., Day P.M., Nowak T., Selinka H.C., Florin L., Bolscher J., Hilbig L., Schiller J.T., Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 2006, 80(2):759-768.
36. Kawana K., Yoshikawa H., Taketani Y., Yoshiike K., Kanda T. Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J. Virol. 1999, 73(7):6188-6190.
37. Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(24):12180-12184.
38. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., Lowy D.R., Schiller J.T. Efficient self-assembly of human papillomavirus type 16L1 and L1-L2 into virus-like particles. J. Virol. 1993, 67(12):6929-6936.
39. Kozak M. The scanning model for translation: an update. J. Cell Biol. 1989, 108(2):229-241.
40. Laniosz V., Nguyen K.C., Meneses P.I. Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18. J. Virol. 2007, 81(14):7435-7448.
41. Lin J.Y., Li M.L., Shih S.R. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009, 37(1):47-59.
42. Mayer T.J., Meyers C. Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b. Virology 1998, 248(2):208-217.
43. McLaughlin-Drubin M.E., Bromberg-White J.L., Meyers C. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 2005.
44. McLaughlin-Drubin M.E., Christensen N.D., Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology 2004, 322(2):213-219.
45. McLaughlin-Drubin M.E., Meyers C. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 2004, 321(2):173-180.
46. McLaughlin-Drubin M.E., Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Meth. Mol. Med. 2005, 119:171-186.
47. McLaughlin-Drubin M.E., Wilson S., Mullikin B., Suzich J., Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology 2003, 312(1):1-7.
48. McMillan N.A., Payne E., Frazer I.H., Evander M. Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 1999, 261(2):271-279.
49. Meyers C. Organotypic (raft) epithelial tissue culture system for the differentiation-dependent replication of papillomavirus. Meth. Cell Sci. 1996, 18:1-10.
50. Meyers C., Alam S., Mane M., Hermonat P.L. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue. Virology 2001, 287(1):30-39.
51. Meyers C., Bromberg-White J.L., Zhang J., Kaupas M.E., Bryan J.T., Lowe R.S., Jansen K.U. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J. Virol. 2002, 76(10):4723-4733.
52. Meyers C., Frattini M.G., Hudson J.B., Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992, 257(5072):971-973.
53. Meyers C., Mayer T.J., Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 1997, 71(10):7381-7386.
54. Milligan S.G., Veerapraditsin T., Ahamet B., Mole S., Graham S.V. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 2007, 360(1):172-181.
55. Modis Y., Trus B.L., Harrison S.C. Atomic model of the papillomavirus capsid. EMBO J. 2002, 21(18):4754-4762.
56. Nardelli-Haefliger D., Roden R.B., Benyacoub J., Sahli R., Kraehenbuhl J.P., Schiller J.T., Lachat P., Potts A., De Grandi P. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 1997, 65(8):3328-3336.
57. Okun M.M., Day P.M., Greenstone H.L., Booy F.P., Lowy D.R., Schiller J.T., Roden R.B. L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J. Virol. 2001, 75(9):4332-4342.
58. Ozbun M., Meyers C. Human papillomavirus type 31b transcription during the differentiation-dependent viral life cycle. Curr. Top. Virol. 1999, 1:203-217.
59. Ozbun M.A., Meyers C. Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J. Virol. 1996, 70(8):5437-5446.
60. Ozbun M.A., Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 1997, 71(7):5161-5172.
61. Ozbun M.A., Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 1998, 248(2):218-230.
62. Ozbun M.A., Meyers C. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 1998, 72(4):2715-2722.
63. Ozbun M.A., Meyers C. Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation. J. Virol. 1999, 73(4):3505-3510.
64. Rizk R.Z., Christensen N.D., Michael K.M., Muller M., Sehr P., Waterboer T., Pawlita M. Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J. Gen. Virol. 2008, 89(Pt 1):117-129.
65. Roden R.B., Day P.M., Bronzo B.K., Yutzy W.H.t, Yang Y., Lowy D.R., Schiller J.T. Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. J. Virol. 2001, 75(21):10493-10497.
66. Roden R.B., Kirnbauer R., Jenson A.B., Lowy D.R., Schiller J.T. Interaction of papillomaviruses with the cell surface. J. Virol. 1994, 68(11):7260-7266.
67. Roden R.B., Weissinger E.M., Henderson D.W., Booy F., Kirnbauer R., Mushinski J.F., Lowy D.R., Schiller J.T. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 1994, 68(11):7570-7574.
68. Rossi J.L., Gissmann L., Jansen K., Muller M. Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum. Gene Ther. 2000, 11(8):1165-1176.
69. Sen E., Alam S., Meyers C. Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 2004, 78(2):612-629.
70. Stoneley M., Willis A.E. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 2004, 23(18):3200-3207.
71. Taichman L.P., LaPorta R.F. The expression of papillomaviruses in epithelial cells. The Papillomaviruses 1986, Vol. 2:109-139. Plenum Press, New York.
72. Xi S.Z., Banks L.M. Baculovirus expression of the human papillomavirus type 16 capsid proteins: detection of L1-L2 protein complexes. J. Gen. Virol. 1991, 72(Pt 12):2981-2988.
73. Yang R., Day P.M., Yutzy W.H.t, Lin K.Y., Hung C.F., Roden R.B. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 2003, 77(6):3531-3541.
74. Yang R., Yutzy W.H., Viscidi R.P., Roden R.B. Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. J. Biol. Chem. 2003, 278(14):12546-12553.
75. Zhou J., Crawford L., McLean L., Sun X.Y., Stanley M., Almond N., Smith G.L. Increased antibody responses to human papillomavirus type 16L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes. J. Gen. Virol. 1990, 71(Pt 9):2185-2190.
76. Zhou J., Sun X.Y., Louis K., Frazer I.H. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2N-terminal sequence. J. Virol. 1994, 68(2):619-625.
77. Zhou J., Sun X.Y., Stenzel D.J., Frazer I.H. Expression of vaccinia recombinant HPV 16L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991, 185(1):251-257.
78. Zhou J.A., McIndoe A., Davies H., Sun X.Y., Crawford L. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1. Virology 1991, 181(1):203-210.